Provensis patents expiration
1. Varithena patents expiration
VARITHENA's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US7731986 | PROVENSIS | Therapeutic foam |
Nov, 2024
(1 year, 1 month from now) | |
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6846412 | PROVENSIS | Combination filter assembly |
Jul, 2022
(1 year, 2 months ago) | |
| US8122917 | PROVENSIS | Apparatus and method for dispensing foam |
Sep, 2024
(11 months from now) | |
| US7814943 | PROVENSIS | Apparatus and method for dispensing foam |
Nov, 2027
(4 years from now) | |
| US9480652 | PROVENSIS | Aerosol valve |
May, 2032
(8 years from now) | |
Drugs and Companies using POLIDOCANOL ingredient
Market Authorisation Date: 25 November, 2013
Treatment: A method of generating an injectable foam of controlled density and bubble size; A method of intravenous injection using ultrasound guidance, administered via a single cannula into the lumen of the ta...
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
VARITHENA family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic